NOTCH1 and glioblastoma: Interestingly, while the majority of patients with glioblastoma (73%) did not harbor a discernible alteration, 27% (N=9/33) had an alteration (Figure 2B), most commonly TP53 and NOTCH1 anomalies (detected in four and three patients, respectively).